Publications by authors named "Maria Barbieri"

Claim this Profile
L
Low-dose aspirin and risk of anaemia in older adults: insights from a Danish register-based cohort study.
Maria Antonietta Barbieri, Dilsad Simay Peker, Mohsen Gamal Saad Askar, Vera Battini, Andrea Abate

Eur Heart J Qual Care Clin Outcomes· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Predicting Readmission to the Emergency Department After a Diagnosis of Acute Respiratory Infection: A Two-year Experience at a Pediatric Tertiary Care Hospital in Italy.
Elisa Cappelli, Marta Ciofi Degli Atti, Lucilla Ravà, Benedetta Zama, Carmen D'Amore, Maria Antonietta Barbieri

Pediatr Infect Dis J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity and reliability of the Italian version of the Mild Behavioral Impairment Checklist in cognitively unimpaired and mild cognitive impairment individuals.
Francesca Remelli, Federico Triolo, Giulia Grande, Maria Giorgia Barbieri, Elena Barbieri

J Alzheimers Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contaminants in fish and seafood from the marine environment: A global overview of current status and future perspective.
Maria Vittoria Barbieri, María Pilar González, Valentina Araya Piqué, Julián Blasco, Ethel Eljarrat

Mar Pollut Bull· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders.
Marika Alborghetti, Maria Antonietta Barbieri, Ferdinando Nicoletti, Edoardo Spina

Expert Opin Drug Metab Toxicol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurobiological correlates of Mild Behavioral Impairment: a systematic review and meta-analysis.
Francesca Remelli, Maria Giorgia Barbieri, Elena Ferrighi, Federico Triolo, Giulia Grande

Alzheimers Res Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and Clinical Impact of Mycoplasma pneumoniae in an Italian Pediatric Center: An Observational Study from 2017 to 2024.
Marco Bianchi, Mara Pisani, Lara Ricotta, Carmen D'Amore, Anna Chiara Vittucci, Maria Antonietta Barbieri

Pediatr Infect Dis J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence in pharmacovigilance signal management: a review of tools, implementations, research, and regulatory landscape.
Maria Antonietta Barbieri, Vera Battini, Carla Carnovale, Marianna Cocco, Despoina Georgia Papoutsi

Expert Opin Drug Saf· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-the-Shelf Large Language Models for Causality Assessment of Individual Case Safety Reports: A Proof-of-Concept with COVID-19 Vaccines.
Andrea Abate, Elisa Poncato, Maria Antonietta Barbieri, Greg Powell, Andrea Rossi

Drug Saf· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network Analysis and Machine Learning for Signal Detection and Prioritization Using Electronic Healthcare Records and Administrative Databases: A Proof of Concept in Drug-Induced Acute Myocardial Infarction.
Maria Antonietta Barbieri, Andrea Abate, Olivér M Balogh, Mátyás Pétervári, Péter Ferdinandy

Drug Saf· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System.
Maria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala, Giuseppe Andò, Tindara Franchina

Eur J Clin Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014-2023).
Maria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala, Concetta Zito, Edoardo Spina

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance.
Desirèe Speranza, Fausto Omero, Vincenzo Cianci, Mariapia Marafioti, Carla Infurna, Maria Antonietta Barbieri

Pharmaceuticals (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk factors of anemia in internationally adopted children: a cohort study.
Danilo Buonsenso, Ugo Maria Pierucci, Anna Camporesi, Francesca Raffaelli, Maria Chiara Barbieri

Ital J Pediatr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention.
Michelangelo Rottura, Maria Antonietta Barbieri, Carmine Siniscalchi, Pierpaolo Di Micco, Selene Francesca Anna Drago

Front Med (Lausanne)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of intermittent water flow on biodegradation of organic micropollutants in the hyporheic zone.
Maria Vittoria Barbieri, Oriane Della-Negra, Dominique Patureau, Serge Chiron

Chemosphere· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience.
Cosimo Galletti, Federico Sireci, Giovanna Stilo, Maria Antonietta Barbieri, Giuliano Messina

Am J Otolaryngol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal dynamic of soil microbial communities and antibiotic resistance markers exposed to increasing concentrations of sulfamethoxazole.
Oriane Della-Negra, Marilia Camotti Bastos, Maria Vittoria Barbieri, Valérie Bru-Adan, Gaëlle Santa-Catalina

Environ Pollut· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasticizers levels in four fish species from the Ligurian Sea and Central Adriatic Sea (Mediterranean Sea) and potential risk for human consumption.
Chiara Dettoto, Andrea Maccantelli, Maria Vittoria Barbieri, Matteo Baini, Julio Fernández-Arribas

Sci Total Environ· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A newly developed method for assessing co-exposure to free dose combinations: a proof-of-concept study using antihypertensive medications in Danish registers.
Maria Antonietta Barbieri, Sidse Marie Neumann Nielsen, Andrea Rossi, Elena Olmastroni, Manuela Casula

Aging Clin Exp Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure.
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale

Drug Saf· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System.
Giuseppe Cicala, Giulia Russo, Vincenza Santoro, Tindara Franchina, Nicola Silvestris, Maria Antonietta Barbieri

Pharmaceuticals (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care.
Cosimo Galletti, Francesco Ciodaro, Maria Antonietta Barbieri, Fabiana Gambino, Maria Grazia Ferrisi

Am J Otolaryngol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review.
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini

Expert Rev Clin Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data.
Giuseppe Cicala, Maria Antonietta Barbieri, Giulia Russo, Francesco Salvo, Edoardo Spina

Pharmaceuticals (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis